Dutch Consortium Antibiotics and Pharmaceutical Residues from Water

The Dutch Association Innovative Medicines (VIG), the Dutch Generic and Biosimilar Medicines Association (BOGIN), the European Water Stewardship (EWS) and AMR Insights have taken the initiative to establish a Dutch Public-Private Consortium with the aim to support technological solutions and innovation capacity to reduce emissions from antibiotic waste streams. The Consortium targets hospitals, waste water treatment plants and manufacturing plants within and outside the European Union including countries such as China, India and other LMIC’s.

On the short term the action-oriented Consortium will access and provide existing technologies. On the longer term the Consortium will make available highly innovative, more affordable solutions resulting from current and newly initiated research and development work.

The Consortium will connect to and embed in existing, leading global structures. The objective of the Consortium is to reduce the antibiotic emissions with the overarching aim of adding to the global curbing of Antimicrobial resistance (AMR).

Why join the Consortium?

The fight against antimicrobial resistance is a rapidly emerging. There is an increasing global need for new, workable, affordable technologies for the sustainable reduction of emissions from antibiotic production. The consortium responds to this by developing economic opportunities for the participating companies and research challenges for the participating knowledge institutions.

Further information

AMR Insights
Dr Maarten van Dongen
Keizersgracht  482, 1017 EG Amsterdam, The Netherlands
E: Info@AMR-Insights.EU T: +31 (0)20 214 6068 W: AMR-Insights.EU